About ISHARES V PLC

WHCS invests in stocks. The fund's major sectors are Health Technology, with 73.99% stocks, and Health Services, with 13.67% of the basket. The assets are mostly located in the North America region.

WHCS top holdings are Eli Lilly and Company and Novartis AG, occupying 6.87% and 5.20% of the portfolio correspondingly.

WHCS last dividends amounted to 0.03 CHF. Six months before that, the issuer paid 0.04 CHF in dividends, which shows a 38.43% decrease.

WHCS assets under management is ‪402.69 M‬ CHF. It's fallen 3.61% over the last month.

WHCS fund flows account for ‪−276.67 M‬ CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

WHCS shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Oct 17, 2019, and its management style is Passive.

WHCS expense ratio is 0.18% meaning you'd have to pay 0.18% of your investment to help manage the fund.

WHCS follows the MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

WHCS invests in stocks.

WHCS price has risen by 2.38% over the last month, and its yearly performance shows a 2.38% increase. See more dynamics on WHCS price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −1.70% over the last month, have fallen by −1.70% over the last month, showed a −12.51% decrease in three-month performance and has decreased by −16.65% in a year.